Which scientific breakthrough product launch was the first FDA-approved therapy using CRISPR gene-editing technology?

Product launches in the pharmaceutical industry require careful scientific testing, regulatory approval, and strategic marketing. This poll tests your knowledge about one of the most significant scientific product launches of the 21st century that revolutionized how we approach certain diseases. Understanding the science behind successful pharmaceutical product launches provides insights into the complex interplay between scientific innovation, regulatory frameworks, and market dynamics.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

CASGEVY (exagamglogene autotemcel) for sickle cell disease and beta thalassemia
Luxturna (voretigene neparvovec) for inherited retinal dystrophy
Kymriah (tisagenlecleucel) for B-cell acute lymphoblastic leukemia
Spinraza (nusinersen) for spinal muscular atrophy